Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training
Malignant Vascular Neoplasm
What this study involves
The registry says this study is recruiting. Individual locations may have different availability.
- Study type
- Observational
- Phase
- Not applicable / not listed
- Age range
- 18 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Accepted
- Participants
- 9 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
This study looks at the comfort of interventional and diagnostic imaging residents in performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device. Implementation of a training curriculum with radiology residents interested in interventional radiology will help facilitate hands-on training in a low-risk environment and allow for safer future patient encounters.
Read the full description
PRIMARY OBJECTIVE:
I. To measure trainee comfort performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device.
OUTLINE:
Participants complete a survey over 10 minutes before and after completing training and using the Mentice endovascular simulator device.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
\- Current interventional and diagnostic radiology residents participating in the training curriculum on the Mentice Endovascular Simulator will be eligible to participate in the survey
Study population
Current interventional and diagnostic radiology residents participating in the training curriculum on the Mentice Endovascular Simulator at MD Anderson Cancer Center.
Understand screeningTreatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Not reported
- Masking
- Not reported
Observational (survey administration)
Participants complete a survey over 10 minutes before and after completing training and using the Mentice endovascular simulator device.
Other: Survey Administration
Survey Administration OTHER
Complete survey
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Trainees' feelings about using simulation to help with procedural training
Time frame: through study completion, an average of 1 year
Will measure how trainees feel about using simulation to help with procedural training, and how comfortable trainees feel performing various endovascular procedures after undergoing training on the Mentice simulator machine.
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (1)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
1 locations
M D Anderson Cancer CenterHouston, Texas, United StatesRecruiting
Study team and timeline
- Lead sponsor
- M.D. Anderson Cancer Center
- Study start
- Jul 8, 2020 Actual
- Primary completion
- Apr 30, 2028 Estimated
- Study completion
- Apr 30, 2028 Estimated
- First posted
- Apr 6, 2021 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training Regimen
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026
